Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Table of Contents

March 15, 2026; Volume 23,Issue 3
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Bian, Li

    1. Open Access
      Protocol and statistical designs in classic clinical research—toripalimab series trial analysis
      Yingjian He, Li Bian and Zefei Jiang
      Cancer Biology & Medicine March 2026, 23 (3) 338-342; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0759
  2. Bu, Hong

    1. Open Access
      Multimodal artificial intelligence predicts PIK3CA mutation in breast cancer from digital pathology and clinical data: a multicenter study
      Jiaxian Miao, Qi Liu, Jianing Zhao, Shishun Fan, Shenwen Wang, Feng Ye, Si Wu, Jinze Li, Huirui Zhang, Meng Zhang, Hong Bu, Xiao Han, Lianghong Teng and Yueping Liu
      Cancer Biology & Medicine March 2026, 23 (3) 430-450; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0771
  3. Cai, Junchao

    1. Open Access
      Metabolic engineering of SLC38A2 reprograms glutamine utilization and enhances CAR-macrophage antitumor function in solid tumors
      Mingzhu Liu, Qingxi Chen, Luoling Zhang, Yunxuan Zhou, Ning Wen, Jin Jin, Junchao Cai, Shicheng Su, Jiang Li and Qiyi Zhao
      Cancer Biology & Medicine March 2026, 23 (3) 392-417; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0775
  4. Chen, Qingxi

    1. Open Access
      Metabolic engineering of SLC38A2 reprograms glutamine utilization and enhances CAR-macrophage antitumor function in solid tumors
      Mingzhu Liu, Qingxi Chen, Luoling Zhang, Yunxuan Zhou, Ning Wen, Jin Jin, Junchao Cai, Shicheng Su, Jiang Li and Qiyi Zhao
      Cancer Biology & Medicine March 2026, 23 (3) 392-417; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0775
  5. Chen, Yilin

    1. Open Access
      The role of radiomics in predicting the response to neoadjuvant chemotherapy for breast cancer
      Yilin Chen, Ye Qin, Man Yang, Wei Li, Minyi Cheng, Yuhong Huang, Teng Zhu and Kun Wang
      Cancer Biology & Medicine March 2026, 23 (3) 343-362; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0655
  6. Cheng, Minyi

    1. Open Access
      The role of radiomics in predicting the response to neoadjuvant chemotherapy for breast cancer
      Yilin Chen, Ye Qin, Man Yang, Wei Li, Minyi Cheng, Yuhong Huang, Teng Zhu and Kun Wang
      Cancer Biology & Medicine March 2026, 23 (3) 343-362; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0655
  7. Fan, Shishun

    1. Open Access
      Multimodal artificial intelligence predicts PIK3CA mutation in breast cancer from digital pathology and clinical data: a multicenter study
      Jiaxian Miao, Qi Liu, Jianing Zhao, Shishun Fan, Shenwen Wang, Feng Ye, Si Wu, Jinze Li, Huirui Zhang, Meng Zhang, Hong Bu, Xiao Han, Lianghong Teng and Yueping Liu
      Cancer Biology & Medicine March 2026, 23 (3) 430-450; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0771
  8. Gnant, Michael

    1. Open Access
      Balancing global standards and regional nuances in breast cancer care: the role of guidelines, clinical research, precision medicine, and artificial intelligence in advancing quality of care for patients worldwide
      Michael Gnant
      Cancer Biology & Medicine March 2026, 23 (3) 314-319; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0674
  9. Han, Xiao

    1. Open Access
      Multimodal artificial intelligence predicts PIK3CA mutation in breast cancer from digital pathology and clinical data: a multicenter study
      Jiaxian Miao, Qi Liu, Jianing Zhao, Shishun Fan, Shenwen Wang, Feng Ye, Si Wu, Jinze Li, Huirui Zhang, Meng Zhang, Hong Bu, Xiao Han, Lianghong Teng and Yueping Liu
      Cancer Biology & Medicine March 2026, 23 (3) 430-450; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0771
  10. He, Yingjian

    1. Open Access
      Protocol and statistical designs in classic clinical research—toripalimab series trial analysis
      Yingjian He, Li Bian and Zefei Jiang
      Cancer Biology & Medicine March 2026, 23 (3) 338-342; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0759
« Previous (Pages : 1 2 3 4 5 6 ... 7) Next »
Back to top
Previous

In this issue

Cancer Biology & Medicine: 23 (3)
Cancer Biology & Medicine
Vol. 23, Issue 3
15 Mar 2026
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire